PAPER Aggarwal L, Biswas P
SEARCH RESULTS
442 RESULTS
PAPER Zanardi A, Alessio M
Ceruloplasmin Deamidation in Neurodegeneration: From Loss to Gain of Function.
Int J Mol Sci. 2021 Jan 11;22(2) PubMed: 33440850PAPER Hamilton K, Harvey J
The Neuronal Actions of Leptin and the Implications for Treating Alzheimer's Disease.
Pharmaceuticals (Basel). 2021 Jan 11;14(1) PubMed: 33440796PAPER Petretto DR, Carrogu GP, Gaviano L, Pili L, Pili R
Dementia and Major Neurocognitive Disorders: Some Lessons Learned One Century after the first Alois Alzheimer's Clinical Notes.
Geriatrics (Basel). 2021 Jan 11;6(1) PubMed: 33440669PAPER Bell SM, Barnes K, De Marco M, Shaw PJ, Ferraiuolo L, Blackburn DJ, Venneri A, Mortiboys H
Mitochondrial Dysfunction in Alzheimer's Disease: A Biomarker of the Future?
Biomedicines. 2021 Jan 11;9(1) PubMed: 33440662PAPER Skrzypek A, Matysiak J, Karpińska M, Czarnecka K, Kręcisz P, Stary D, Kukułowicz J, Paw B, Bajda M, Szymański P, Niewiadomy A
Biological evaluation and molecular docking of novel 1,3,4-thiadiazole-resorcinol conjugates as multifunctional cholinesterases inhibitors.
Bioorg Chem. 2021 Feb;107:104617. Epub 2021 Jan 5 PubMed: 33444983PAPER Daskalov A, Martinez D, Coustou V, El Mammeri N, Berbon M, Andreas LB, Bardiaux B, Stanek J, Noubhani A, Kauffmann B, Wall JS, Pintacuda G, Saupe SJ, Habenstein B, Loquet A
Structural and molecular basis of cross-seeding barriers in amyloids.
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1) PubMed: 33443172PAPER García S, Cuetos F, Novelli A, Martínez C
A new and short protocol to achieve the early diagnosis of mild cognitive impairment.
Neurol Sci. 2021 Jan 13; PubMed: 33442844PAPER Ahn N, Frenzel S, Wittfeld K, Bülow R, Völzke H, Lerch MM, Chenot JF, Schminke U, Nolde M, Amann U, Meisinger C, Linseisen J, Baumeister SE, Grabe HJ, Rückert-Eheberg IM
Lack of association between proton pump inhibitor use and brain aging: a cross-sectional study.
Eur J Clin Pharmacol. 2021 Jul;77(7):1039-1048. Epub 2021 Jan 13 PubMed: 33442768PAPER Vintimilla R, Balasubramanian K, Hall J, Johnson L, O'Bryant S
Cardiovascular Risk Factors, Cognitive Dysfunction, and Mild Cognitive Impairment.
Dement Geriatr Cogn Dis Extra. 2020 Sep-Dec;10(3):154-162. Epub 2020 Nov 16 PubMed: 33442392PAPER Ostrei U, Efrati-Chomsky D, Zur A, Robes-Alkalay Y, Nave A, Punchik B, Press Y
The Effect of the Feuerstein Project on the Cognitive and Functional State of Community-Dwelling Individuals Aged 65 Years and Older with Mild Cognitive Impairment: A Pilot Study.
Dement Geriatr Cogn Dis Extra. 2020 Sep-Dec;10(3):135-142. Epub 2020 Nov 13 PubMed: 33442390PAPER Blanquisco L, Abejero JE, Buno Ii B, Trajano-Acampado L, Cenina A, Santiago D
Factors Associated with Mild Cognitive Impairment among Elderly Filipinos with Type 2 Diabetes Mellitus.
J ASEAN Fed Endocr Soc. 2017;32(2):145-150. Epub 2017 Sep 6 PubMed: 33442098PAPER Jones A, Morgan-Jones P, Busse M, Shepherd V, Wood F
Conducting focus groups in neurodegenerative disease populations: ethical and methodological considerations.
BMJ Open. 2021 Jan 13;11(1):e041869. PubMed: 33441358PAPER Stephenson D, Alexander R, Aggarwal V, Badawy R, Bain L, Bhatnagar R, Bloem BR, Boroojerdi B, Burton J, Cedarbaum JM, Cosman J, Dexter DT, Dockendorf M, Dorsey ER, Dowling AV, Evers LJ, Fisher K, Frasier M, Garcia-Gancedo L, Goldsack JC, Hill D, Hitchcock J, Hu MT, Lawton MP, Lee SJ, Lindemann M, Marek K, Mehrotra N, Meinders MJ, Minchik M, Oliva L, Romero K, Roussos G, Rubens R, Sadar S, Scheeren J, Sengoku E, Simuni T, Stebbins G, Taylor KI, Yang B, Zach N
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science.
Digit Biomark. 2020;4(Suppl 1):28-49. Epub 2020 Nov 26 PubMed: 33442579PAPER Cummings J
New approaches to symptomatic treatments for Alzheimer's disease.
Mol Neurodegener. 2021 Jan 13;16(1):2. PubMed: 33441154Current Filters
- Date Range : Jan 2021 to Jan 2021 x